Stents, scaffolds and DCB

Explore the future of complex PCI with Meril Life’s advanced solutions. Learn about thin-strut platforms, dedicated stents for side branches and diffuse lesions, the role of drug-eluting balloons in metal-free PCI, and the clinical potential of the Myval THV technology.

DCBs have undergone extensive development to meet the challenges of minimizing restenosis and maintaining vessel patency. Unlike stents, DCBs deliver an antiproliferative drug directly to the arterial wall without leaving a permanent implant. This approach has proven effective in treating small-vessel disease, in-stent restenosis, and de...

The present study compares a novel sirolimus-coated balloon with a clinically proven paclitaxel-coated balloon for the treatment of de novo coronary lesions, demonstrating non-inferiority in terms of angiographic late lumen loss at 6 months.

Discuss the rationale of a PCI strategy with minimal metal as a turning point of vascular interventions with Flavio Luciano Ribichini, Salvatore Brugaletta and Piera Capranzano.

The purpose of this case report is to discuss the treatment of a chronic total occlusion (CTO) in a 58-year-old male patient with multiple cardiovascular risk factors including type 2 diabetes, dyslipidemia, hypertension, and smoking history.

Angio showed a CTO of the RCA. In the MR-Scan, the RCA...

Fernando Alfonso and Javier Cuesta discuss the growing role of drug-coated balloons as an alternative to stents in percutaneous coronary interventions. Highlighting advantages like reduced in-stent restenosis, they emphasize the need for robust clinical studies to refine DCB use.

A 73-year-old male with complex recurrent in-stent restenosis of the left main underwent an innovative treatment approach. Six-month follow-up revealed remarkable recovery and positive remodelling. Discover how Piotr Buszman and Mateusz Kachel tackled this challenging case.

Drug-coated balloon (DCB) angioplasty has become a valuable alternative to drug-eluting stents in treating coronary artery disease. To achieve optimal outcomes, proper lesion preparation and techniques to minimise drug loss are crucial.

This article highlights key steps and best practices for performing DCB angioplasty, ensuring effective drug delivery and...

Authored by Hector Garcia-Garcia and Jorge Sanz-Sanchez, this article examines pivotal randomized clinical trials on drug-coated balloons in coronary artery disease. It highlights their role in managing in-stent restenosis, de novo small vessel lesions, and large vessel lesions while exploring future directions through ongoing trials.

The aim of this pre-specified analysis of the ILUMIEN IV trial was to assess the relationship between post-PCI OCT parameters of suboptimal stent implantation and clinical outcomes.